In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
This study objective was to evaluate the effects of a daily patient reminder on seizure documentation accuracy in adult inpatients with focal epilepsies undergoing video-electroencephalographic monitoring. In conclusion,…
The study explains how a multidisciplinary working group was formed to apply consensus terminology and diagnostic criteria for disorders presenting with diffuse lung disease in infancy. References and…
The objective of this study was to assess the effect of ibuprofen therapy on FEV1 decline in children and adolescents with cystic fibrosis, using observational data from the…
Scientists suspect that overnight work is dangerous because it disrupts the circadian rhythm, and is a potential cause of breast and prostate cancer. References and Resources Stevens RG,…
The U.S. Food and Drug Administration has approved the antipsychotic drug Abilify (aripiprazole) for adolescents aged 13 to 17 diagnosed with schizophrenia. References and Resources U.S. Food and…
This update highlights changes to the prescribing information for Avandia including a new boxed warning about the potential increased risk of myocardial ischemia. References and Resources FDA adds…
Avastin shows promise in a phase II study in glioblastoma multiforme. References and Resources Avastin Clinical Trial Information Click Here to view information. Vredenburgh J, Desjardins A, Herndon…
John A. Daller, MD, PhD, FACS, Associate Professor, Director, Abdominal Organ Transplantation, Temple University School of Medicine, discusses renal transplantation. References and Resources Renal Failure, Chronic and Dialysis…
The FDA has approved Zyrtec-D for nonprescription use in adults and children 12 years of age and older. References and Resources FDA Approves Nonprescription Zyrtec-D for Allergies Click…
Gary S. Cohen, MD, Chief, Vascular Interventional Radiology, Vice Chairman of Clinical Services, Professor of Radiology, Temple University School of Medicine, discusses uterine artery embolization. References and Resources…
